CELL AND GENE THERAPY INSIGHTS

Filter by Interests

Filter by ContentType

Automated cryopreservation process development for leukapheresis to support supply chains

Automated cryopreservation process development for leukapheresis to support supply chains

Alexandre Michaux
16 September 2024
FastFacts
 Optimizing HEK293-based viral vector production, part 1: cell lines and media

Optimizing HEK293-based viral vector production, part 1: cell lines and media

Sandra Klausing, David Ede
07 February 2024
FastFacts
 Improving cell viability through controlled freezing

Improving cell viability through controlled freezing

Brian Moloney
31 January 2024
FastFacts
 Cell culture in a chemically defined environment

Cell culture in a chemically defined environment

Chengkang Zhang
29 November 2023
FastFacts
 Using a data-driven approach to deliver complex studies in advanced therapeutics

Using a data-driven approach to deliver complex studies in advanced therapeutics

Vito Romita, Jai Balkissoon
21 June 2023
FastFacts
 Navigating the gene & cell therapy regulatory landscape: when, why and how to deploy GMP gene editing materials

Navigating the gene & cell therapy regulatory landscape: when, why and how to deploy GMP gene editing materials

Michael Lau
13 June 2023
FastFacts
 Increase quality & standardization of cellular starting material

Increase quality & standardization of cellular starting material

Matt Hemstreet
02 June 2023
FastFacts
 Benefits of upstream seed train intensification & high-density cell banking

Benefits of upstream seed train intensification & high-density cell banking

Patrick Shu Miao
09 March 2023
FastFacts
 Find your competitive advantage through custom buffer formulations for CAR-T manufacturing

Find your competitive advantage through custom buffer formulations for CAR-T manufacturing

Benito Delgado
04 January 2023
FastFacts
 Cell collection in cell therapy — quality matters

Cell collection in cell therapy — quality matters

Sara Lewandowski
14 December 2022
FastFacts
 Leveraging the power of AI to design the best performing iPSC culture media

Leveraging the power of AI to design the best performing iPSC culture media

Asma Ayari
13 September 2022
FastFacts
 Cell & Gene therapy supply chain orchestration explained

Cell & Gene therapy supply chain orchestration explained

Andreas Göbel, Camila Mendes
17 July 2022
FastFacts
 Key considerations for cytokine supplier selection for cell therapies

Key considerations for cytokine supplier selection for cell therapies

Timothy Manning
01 July 2022
FastFacts
 Key factors in cell cryopreservation and impact on manufacturability of cell and gene therapies

Key factors in cell cryopreservation and impact on manufacturability of cell and gene therapies

Robert Newman, PhD
12 April 2022
FastFacts
 Leveraging lessons from the COVID-19 pandemic to accelerate the development and production of viral-based gene therapies

Leveraging lessons from the COVID-19 pandemic to accelerate the development and production of viral-based gene therapies

Yasser Kehail
05 October 2021
FastFacts
 Getting closer to the in vivo environment with human AB serum

Getting closer to the in vivo environment with human AB serum

Trevor Smith
31 August 2021
FastFacts
 The importance of a strong collection cell collection network during the COVID-19 pandemic

The importance of a strong collection cell collection network during the COVID-19 pandemic

Chris McClain, MBA
11 February 2021
FastFacts
 Navigating cell therapy supply chain complexities during the COVID-19 pandemic

Navigating cell therapy supply chain complexities during the COVID-19 pandemic

Erin Rasch
16 December 2020
FastFacts
 Managing donor collections during the COVID-19 pandemic

Managing donor collections during the COVID-19 pandemic

Joy Aho
04 November 2020
FastFacts